Para promover la investigación clínica, básica y trasnacional en el campo de la patología metabólica ósea, se ha resuelto la convocatoria de Becas de investigación 2015 de la FEIOMM. Consulte la resolución aquí.
RUTA DE LA SALUD, UNA FORMA DE DIFUNDIR EL CONOCIMIENTO DE LA OSTEOPOROSIS. Ver resolución aquí.
XX Congreso SEIOMM – Bilbao: El jurado, compuesto por los moderadores de las sesiones de comunicaciones orales y pósters y el Comité Científico del XX Congreso de la SEIOMM, ha otorgado los Premios Italfármaco 2015 … Leer más
Mejor comunicación presentada por un investigador socio menor de 35 años: Dra.Blanca Torrubia “EFECTO BENEFICIOSOS DEL ACEITE DE OLIVA SOBRE LA BIOMECÁNICA Y MORFOMETRÍA ÓSEA EN RATAS OVARIECTOMIZADAS.”
DM worsens bone alterations of aged mice, related to decreased bone turnover and bone vasculature and increased senescence, independently of the anti-oxidative stress machinery.
We identified a low-frequency non-coding variant near a novel locus, EN1, with an effect size fourfold larger than the mean of previously reported common variants for lumbar spine BMD (rs11692564) which was also associated with … Leer más
Sclerostin and estradiol levels are associated with the response to bisphosphonate therapy in women with postmenopausal osteoporosis.
The application of the NOGG and NOF guidelines led to a decrease in BMD indications, reducing costs and improving efficiency in the diagnostic management of osteoporosis, although variability exists between the guidelines.
A986S polymorphism of CaSR is an independent predictor of PTH level in normocalcemic hyperparathyroidism patients, but not in asymptomatic hyperparathyroidism.
A target concentration of 40 ng/ml 25(OH)D may prevent development of AIrA. We also demonstrate that AIrA is genetically determined: single nucleotide polymorphisms located in genes encoding key factors for the metabolism of estrogens and … Leer más
